Acute interstitial nephritis (AIN) is an immunologically mediated condition that represents a significant cause of acute kidney injury (AKI). It is characterised by diffuse inflammatory infiltrates ...
Interstitial nephritis is a condition in which a part of your kidneys, called the interstitium, gets inflamed. It can be mild and short-term or more severe and longer-term. It is usually caused by ...
The incidence is creeping back up, however, and the first revelation is that it is proton pump inhibitors (PPIs) and immune checkpoint inhibitors (ICIs) that fuel the contemporary incidence of AIN, ...
Immune checkpoint inhibitors are increasingly used as anti-cancer treatments; however, their use can be associated with the development of immune-related adverse events, including acute kidney injury.
Please provide your email address to receive an email when new articles are posted on . Researchers found patients who were diagnosed with acute interstitial nephritis had higher levels of urinary TNF ...
Researchers from both Johns Hopkins Medicine and Yale University collaborated on the development and application of a diagnostic model to detect acute interstitial nephritis (AIN) in patients, which ...
Steroid treatment of acute interstitial nephritis (AIN) leads to greater improvement in estimated glomerular filtration rate (eGFR) and fewer patients progressing to end-stage renal disease (ESRD), ...
Researchers say they have identified two protein biomarkers in urine that may one day be used to better diagnose acute interstitial nephritis (AIN), an underdiagnosed but treatable kidney disorder ...
Acute interstitial nephritis (AIN) is an inflammatory kidney disorder involving interstitial edema and leukocyte infiltration. This condition can lead to impaired renal function. Medications are among ...
Please provide your email address to receive an email when new articles are posted on . The patient was a recent kidney transplant recipient with recurring infection. E. coli was consistently ...
Efficacy of immune checkpoint inhibitors (ICI) treatment in special populations of metastatic renal cell carcinoma (mRCC). This is an ASCO Meeting Abstract from the 2020 Genitourinary Cancers ...
Nephropathy due to penicillin or methicillin was observed in seven patients. Maximum dosage ranged from 20 to 24 gm per day for methicillin and from 20,000,000 to 60,000,000 units for penicillin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results